AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. FFAI
5. FFR
6. META
7. CART
8. LLY
9. TSLA
10. FICO

Go back to AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results

AngioDynamics (ANGO) Tops Q3 EPS by 4c, Revenues Beat

April 7, 2020 7:02 AM EDT

AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.01, $0.04 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $69.8 million versus the consensus estimate of $68.55 million.

Third Quarter 2020 Financial Results

Net sales for the third quarter of fiscal 2020 were $69.8 million, an increase of 6.5% compared to the prior-year quarter. Excluding the impact of Asclera sales, which were discontinued during fiscal year 2019, net sales grew 9.3% year over year. Foreign currency translation did not have a significant impact on the Companys sales in the quarter.

Oncology net sales were $14.6 million, an... More